Abstract: In a method of controlling a wheel loader, the wheel loader is moved forwards such that a bucket penetrates into an aggregate to perform an excavation work. Signals able to be used to determine tire slip of the wheel loader are obtained during the excavation work. Prediction algorithms obtained through training are performed to determine whether or not the tire slip occurs. In case of the tire slip, an engine speed is decreased and the bucket is lifted to remove the tire slip. The bucket is moved along a predetermined autonomous excavation trajectory when the tire slip is removed.

Abstract: The invention relates to pharmaceutical compositions comprising a zinc2+ salt and a ?-polyglutamic acid carrier, and, optionally, an NF-?B inhibitor as a tumor-sensitizing agent, and methods for using such compositions to treat tumors in patients. Methods include administering a liquid dosage form or a solid dosage form of a therapeutically effective amount of a Zn(II) salt and a ?-polyglutamic acid carrier to a patient in need thereof. Methods of treating a broad spectrum of human tumors, including tumors with a drug-resistant phenotype, using the disclosed compositions are provided. Tumors that respond to the pharmaceutical compositions disclosed herein include neuroendocrine (neuroblastoma), gastric, uterine, and lung tumors.

Abstract: The present invention relates to fluorine substituted cation-disordered lithium metal oxides for high capacity lithium-ion battery electrodes suitable for use in lithium-ion rechargeable batteries having a general formula: Li1+xM1?xO2?yFy, wherein 0.05?x?0.3 and 0<y?0.3 and M is a transition metal, such as Ti, V, Cr, Mn, Fe, Co, Ni, Zr, Nb, Mo, Sn, Sb, and combinations thereof. The fluorine-substituted cation-disordered materials of the present invention demonstrate improved electrochemical performance, showing high capacity and high voltage. The present invention also relates to methods of making the fluorine-substituted cation-disordered materials.

Abstract: A display panel driver includes a storage unit configured to store an align pattern and a timing controller configured to output align image data based on an align control signal provided from a facility driver during a mechanism assembly process of a display panel. The align pattern includes an align mark, and the align image data includes the align pattern.

Abstract: A display device includes: a display panel comprising a display area configured to display an image, wherein the display area includes a measurement area including a plurality of sub-measurement areas, and each of the plurality of sub-measurement areas includes a plurality of pre-map areas; a data driver configured to provide data voltages to the display panel; a signal controller; and a common voltage generator configured to provide a common voltage to the display panel, wherein an afterimage reduction mode is driven to change a level of the common voltage provided by the common voltage generator when the determined pre-map areas are adjacent to each other.

Abstract: A display device is capable of substantially reducing or preventing warping or deformation thereof by using a bimetallic effect. The display device includes a backlight unit including at least one light source; a light source circuit board at which the light source is disposed; a first heat dissipation plate configured to receive heat generated from the light source through the light source circuit board, and to discharge the heat; a bottom case configured to accommodate the light source, the light source circuit board, and the first heat dissipation plate; and a second heat dissipation plate configured to resist a deformation force that is applied to the first heat dissipation plate or the bottom case, the second heat dissipation plate has a thermal expansion coefficient different from a thermal expansion coefficient of the first heat dissipation plate.

Abstract: A display device includes a display panel, and a backlight unit disposed below the display panel. The backlight unit includes a bottom cover including a bottom portion and a side wall protruding from the bottom portion, a light source accommodated in the bottom cover, a middle mold supported by the bottom cover, where the middle mold includes a seating portion and an elastic portion mounted on the seating portion, a diffusion plate supported by the elastic portion, and an optical sheet disposed on the elastic portion. The seating portion and the elastic portion include different materials from each other. The elastic portion has a side end portion that defines a depression for accommodating an end portion of the diffusion plate.

Abstract: A lithium metal oxide suitable for use as a cathode material in a rechargeable battery having a general formula of: LixMzM?zOuFy, where x is 1.80<x<2.20, y=1, and more specifically 1.90<x<2.10, with 1.80<u<2.20. Preferably, 1.90<u<2.10, and 0.80<y<1.20, or more specifically, 0.90<y<1.10. The lithium metal oxide has a cation-disordered rocksalt structure, wherein M is a transition metal selected from a first group consisting of Ni, Mn, Co, Fe, and combinations thereof. M? is a transition metal selected from a second group consisting of Ti, Zr, Nb, Mo, Sn, Hf, Te, Sb, and combinations thereof. M has a first oxidation state q and M? has a second oxidation state q?, with (q/z)+(q?/z?)=+3, preferably +2.7?q/z)+(q?/z?)?+3.3.

Abstract: Disclosed is a prostate cancer diagnostic biomarker composition including, as an active ingredient, at least one kynurenine pathway metabolite selected from kynurenine and anthranilate. Also disclosed are a prostate cancer diagnostic composition including an agent capable of measuring the level of the biomarker and a prostate cancer diagnostic kit including the prostate cancer diagnostic composition. The use of the prostate cancer diagnostic biomarker composition can significantly improve the accuracy of prostate cancer diagnosis as an alternative or supplement to the use of PSA levels for prostate cancer diagnosis according to the prior art, which has difficulty in ensuring accurate diagnosis. Therefore, the biomarker composition can be widely used in a variety of industrial applications, including medical applications.

Abstract: A bottom protection film for an OLED panel is provided. More particularly, a bottom protection film for an OLED panel, which has excellent alignment process workability and excellent adhesion to an OLED panel, and is capable of preventing static electricity through an antistatic treatment and preventing an electrical short circuit at the same time, and an organic light-emitting display device including the bottom protection film are provided.

Abstract: A lower part protection film for an OLED panel is provided. More particularly, a lower part protection film for an OLED panel, having a significantly improved recognition rate of an alignment process, being capable of preventing generation of static electricity through an antistatic treatment, and having excellent adhesion to an OLED panel at the same time, and an organic light-emitting display apparatus including the lower part protection film for an OLED panel are provided.

Abstract: Provided is a display device. The display device includes a display panel including a first side extending in a first direction, a plurality of printed circuit boards each facing the first side, and a plurality of flexible circuit films connected to the first side and the printed circuit boards. Lengths of the flexible circuit films in a second direction intersecting the first direction increase from a first point defined as a predetermined point of the first side to an end of the first side. First sides of at least one of the plurality of flexible circuit films connected to a printed circuit board of the plurality of printed circuit boards has a predetermined angle with respect to the first direction so as to have an inclined surface.

Abstract: A display apparatus includes a display panel bendable in a bending direction about a bending axis, pad units disposed on one side of the display panel and arranged in the bendable direction, printed circuit boards disposed below the display panel, and flexible printed circuit boards configured to connect the display panel to the printed circuit boards. The printed circuit boards are bendable in the bending direction about the bending axis, are arranged in the bendable direction, and extend in the bendable direction. Each of the flexible printed circuit boards has a first end connected to the display panel and a second end connected to one of the printed circuit boards. A second distance between the second ends of two of the flexible printed circuit boards respectively connected to two adjacent printed circuit boards is greater than a first distance between the first ends of the two flexible printed circuit boards.

Abstract: A bottom protection film for an OLED panel is provided. More particularly, a bottom protection film for an OLED panel, the bottom protection film having excellent bending performance due to elasticity and impact resistance, excellent alignment process workability, and excellent adhesion to an OLED panel, and being capable of preventing generation of static electricity through performing an antistatic treatment is provided.

Abstract: A signal compression method, a signal compression apparatus, a vehicle, and a distance measurement system are provided, which can compress the LiDAR sensor signal without a loss. The signal compression method includes a division operation in which data detected by a distance measurement device is divided into a distance component and an angle component; and a preprocessing operation in which at least one of rearranging the angle component and inserting a dummy signal into arrangement of the angle component is performed such that the arrangement of the angle component has periodicity.

Abstract: The invention relates to pharmaceutical compositions comprising a zinc2+ salt and a ?-polyglutamic acid carrier, and, optionally, an NF-kB inhibitor as a tumor-sensitizing agent, and methods for using such compositions to treat tumors in patients. Methods include administering a liquid dosage form or a solid dosage form of a therapeutically effective amount of a Zn(II) salt and a ?-polyglutamic acid carrier to a patient in need thereof. Methods of treating a broad spectrum of human tumors, including tumors with a drug-resistant phenotype, using the disclosed compositions are provided. Tumors that respond to the pharmaceutical compositions disclosed herein include neuroendocrine (neuroblastoma), gastric, uterine, and lung tumors.

Abstract: The invention relates to compositions for administering zinc, including nutritional supplement compositions, comprising ?-polyglutamic acid, a zinc salt, and a gastro-resistant material for use as a dietary supplement to provide zinc to persons desiring or in need thereof, and methods for preparing such compositions as solid dosage forms such as tablets and capsules, and as liquid dosage forms.

Abstract: A method of driving a liquid crystal display panel is provided. The liquid crystal display panel includes: a liquid crystal display pixel including a liquid crystal structure including a pixel electrode, a liquid crystal layer, and a common electrode; a switching transistor connected between the pixel electrode of the liquid crystal structure and a data-line; and a storage capacitor connected to the pixel electrode of the liquid crystal structure. The method includes: calculating an accumulated driving time of the liquid crystal display panel by accumulating a driving time of the liquid crystal display panel; determining whether or not the accumulated driving time has reached a deterioration reference time; and when the accumulated driving time is determined to have reached the deterioration reference time, changing a gate-off voltage applied to a gate terminal of the switching transistor and a common voltage applied to the common electrode.

Abstract: A storage vessel for an extremely low temperature material for reducing a vaporization rate by forming a plating layer at an outer surface of a discharge pipe thereof is provided.

Abstract: A vehicle includes: a navigation device configured to receive position information of the vehicle; a communicator configured to receive a detailed map of a road; a sensor configured to detect an obstacle in the vicinity of the vehicle; and a controller configured to detect at least one adjacent vehicle when the vehicle is located near an intersection, and configured to identify a driving intention of the adjacent vehicle by matching a route of the detected adjacent vehicle with the detailed map of the road.